This dataset provides the number of opioid agonist prescriptions dispensed per provider specialty. The specialties are based on CMS taxonomy.

This dataset provides the number of stimulant prescriptions dispensed per provider specialty. The specialties are based on CMS taxonomy.

This dataset provides the number of patients, gender, & age group of those who received a dispensed prescription for the specified drug class. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS).

This dataset shows the number of authorized licensees, gateway licensees who searched and the number of searches. The gateway allows prescribers and pharmacists to search the patients directly through their electronic health records (EHRs) and pharmacy management systems (PMS)

This dataset shows the percentages of new and refill dispensed prescriptions. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS).

This dataset shows how dispensed prescriptions were paid for. It only includes dispensations to CT residents reported to the CT Prescription Monitoring & Reporting System (CPMRS).

This provides the number of CT prescribers who prescribed a controlled substance drug schedule II -V. In CT, only prescribers who posses an active controlled substance registration (CSP) & DEA number are allowed to prescribed a controlled substance.

This dataset provides the number of users and number of searches conducted in the CT Prescription Monitoring & Reporting System (CPMRS). CT law mandates that all prescribers who posses an active Controlled Substance Registration (CSP) must register with the CPMRS. Additionally, CT has CPMRS usage requirements for prescribers.

This dataset includes the Top 5 Stimulant prescriptions dispensed on a quarterly basis, showing the last day of the preceding quarter. Drug names presented are the generic classification. Prescription stimulants are controlled substances, which increase alertness and energy, enhancing focus. Stimulants are commonly used to treat attention-deficit hyperactivity disorders (ADHD).

Washington’s PMP was created (RCW 70.225 (2007)) to improve patient care and to stop prescription drug misuse by collecting dispensing records for Schedule II, III, IV and V drugs, and by making the information available to medical providers and pharmacists as a patient care tool. Program rules, WAC 246-470, took effect August 27, 2011. The program started data collection from all dispensers October 7, 2011. Under RCW 70.225.040(5)(a), the department is authorized to publish public data after removing information that could be used directly or indirectly to identify individual patients, requestors, dispensers, prescribers, and persons who received prescriptions from dispensers. The data available here are de-identified, and exclude patient, prescriber, and dispenser related information in alignment with program rules WAC 246-470-080. No requestor information is available here. Prescriptions excluded from PMP include those dispensed outside of WA State, those prescribed for less than or equal to 24 hours, those administered or given to a patient in the hospital, and those dispensed from a Department of Corrections pharmacy (unless an offender is released with a prescription), an Opioid Treatment Program, and some federally operated pharmacies (Indian Health Services and Veterans Affairs report voluntarily since 2015). Further information on collection and management of PMP data at DOH can be found at www.doh.wa.gov/pmp/data.